High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications

Chemistry and Biology

Volumn 6, Issue 2, 1999, Pages 71-83

  Stockwell, Brent R ^a   Haggarty, Stephen J ^a   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Cell based assay; Chemical genetics; High throughput screening; Post translational; Profiling

Indexed keywords

ASSAY; CYTOBLOT; IMMUNOANALYSIS; IMMUNODETECTION; MOLECULAR AND CELLULAR STRUCTURE;

MAMMALIA;

EID: 0033080348     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80004-0     Document Type: Article

References (61)

1. Nadeau, J.H. & Dunn, P.J. (1998). Genomic strategies for defining and dissecting developmental and physiological pathways. Curr. Opin. Genet. Dev. 8, 311-315.
2. Schimenti, J. & Bucan, M. (1998). Functional genomics in the mouse: Phenotype-based mutagenesis screens. Genome Res. 8, 698-710.
3. Harrison, R.G. (1910). The outgrowth of the nerve fiber as a mode of protoplasmic movement. J. Exp. Zool. 9, 787-848.
4. Xiong, J.-W., Battaglino, R., Leahy, A. & Stuhlmann, H. (1998). Large-scale screening for developmental genes in embryonic stem cells and embryoid bodies using retroviral entrapment vectors. Dev. Dyn. 212, 181-197.
5. Dymecki, S.M. (1996). A modular set of Flp, FRT and lacz fusion vectors for manipulating genes by site-specific recombination. Gene 171, 197-201.
6. Capecchi, M.R. (1989). Altering the genome by homologous recombination. Science 244, 1288-1292.
7. Couture, L.A. & Stinchcomb, D.T. (1996). Anti-gene therapy: The use of ribozymes to inhibit gene function. Trends Genet. 12, 510-515.
8. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey, E.J. & Schreiber, S.L. (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268, 726-731.
9. Mitchison, T.J. (1994). Towards a pharmacological genetics. Chem. Biol. 1, 3-6.
10. Pang, L., Sawada, T., Decker, S.J. & Saltiel, A.R. (1995). Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270, 13585-13588.
11. Liu, J., Farmer, J.D., Lane, W.S., Friedman, J., Weissman, I. & Schreiber, S.L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
12. Panek, R.L., et al., & Brown, K.J. (1998). In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J. Pharmacol. Exp. Ther. 286, 569-577.
13. Kohl, N.E., et al., & Lee, T.J. (1994). Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc. Natl Acad. Sci. USA 91, 9141-9145.
14. Tantillo, C., et al., & Arnold, E. (1994). Locations of anti-AIDs drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243, 369-387.
15. Crabtree, G.R. & Schreiber, S.L. (1996). Three-part inventions: Intracellular signaling and induced proximity. Trends Biochem. Sci. 21, 418-422.
16. Tian, S.S., et al., & Rosen, J. (1998). A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science 281, 257-259.
17. Rohrer, S.P., et al., & Schaeffer, J.M. (1998). Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282, 737-740.
18. Engvall, E. & Perlman, P. (1971). Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 9, 871-874.
19. Schneppenheim, R., Budde, U., Dahlmann, N. & Rautenberg, P. (1991). Luminography - A new, highly sensitive visualization method for electrophoresis. Electrophoresis 12, 367-372.
20. Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350-4354.
21. Tijssen, P. & Kurstak, E. (1984). Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibody conjugates for enzyme immunoassay. Anal. Biochem. 136, 451 -457.
22. Tucker, R.F., Shipley, G.D., Moses, H.L. & Holley, R.W. (1984). Growth inhibitor from BSC-1 cells is closely related to the platelet type β transforming growth factor. Science 226, 705-707.
23. Laiho, M., DeCaprio, J.A., Ludlow, J.W., Livingston, D.M. & Massague, J. (1990). Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62, 175-185.
24. Magaud, J.-P., Sargent, I. & Mason, D.Y. (1988). Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake. J. Immunol. Methods 106, 95-100.
25. Muir, D., Varon, S. & Manthorpe, M. (1990). An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures. Anal. Biochem. 185, 377-382.
26. Gratzner, H.G. (1982). Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218, 474-475.
27. Hartwell, L.H. (1991). Twenty-five years of cell-cycle genetics. Genetics 4, 975-980.
28. You, A.J., Jackman, R.J., Whitesides, G.M. & Schreiber, S.L. (1997). A miniaturized arrayed assay format for detecting small molecule-protein interactions in cells. Chem. Biol. 4, 969-975.
29. Hung, D.T., Jamison, T.F. & Schreiber, S.L. (1996). Understanding and controlling the cell cycle with natural products. Chem. Biol. 3, 623-640.
30. Jacks, T., et al., & Weinberg, R.A. (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1 -7.
31. Brugarolas, J., Bronson, R.T. & Jacks, T. (1998). p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J. Cell Biol. 141, 503-514.
32. Lew, D.J. & Kornbluth, S. (1996). Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell. Biol. 6, 795-804.
33. Hassig, C.A. & Schreiber, S.L. (1997). Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1, 300-308.
34. Gabay, L., Seger, R. & Shilo, B.Z. (1997). In situ activation of Drosophila EGF receptor pathway during development. Science 277, 1103-1106.
35. Taunton, J., Hassig, C.A. & Schreiber, S.L. (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411.
36. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. & Fusenig, N.E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771.
37. Mahadevan, L.C., Willis, A.C. & Barratt, M.J. (1991). Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid and protein synthesis inhibitors. Cell 65, 775-783.
38. Anderson, H.J., de Jong, G., Vincent, I. & Roberge, M. (1998). Flow cytometry of mitotic cells. Exp. Cell Res. 238, 498-502.
39. Vincent, I., Rosado, M. & Davies, P. (1996). Mitotic mechanisms in Alzheimer's disease. J. Cell Biol. 132, 413-425.
40. Roberge, M., et al., & Anderson, R.J. (1998). High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Res 58, 5701-5706.
41. Tan, D.S., Foley, M.A., Shair, M.D. & Schreiber, S.L. (1998). Stereoselective synthesis of over two million compounds having structural features both reminiscent of natural products and compatible with miniaturized cell-based assays. J. Am. Chem. Soc. 120, 8565-8566.
42. Fretz, H., et al., & Schreiber, S.L (1991). Rapamycin and FK506 binding proteins (immunophilins). J. Am. Chem. Soc. 113, 1409-1411.
43. Brown, E.J., et al., & Schreiber, S.L. (1994). A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758.
44. Okada, T.A., Roberts, E. & Brodie, A.F. (1967). Mitotic abnormalities produced by juglone in Ehrlich ascites tumor cells. Proc. Soc. Exp. Biol. Med. 126, 583-588.
45. Hennig, L., et al., & Fischer, G. (1998). Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37, 5953-5960.
46. Lu, K.P., Hanes, S.D. & Hunter, T. (1996). A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380, 544-547.
47. Shen, M., Stukenberg, P.T., Kirschner, M.W. & Lu, K.P. (1998). The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 12, 706-720.
48. Downes, C.S., Clarke, D.J., Mullinger, A.M., Giménez-Abián, J.F., Creighton, A.M. & Johnson, R.T. (1994). A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372, 467-470.
49. Meijer, L., et. al., & Moulinoux, J.P. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536.
50. Blundell, T.L. (1996). Structure-based drug design. Nature 384, 23-26.
51. Borchardt, A., Liberles, S.D., Biggar, S.R., Crabtree, G.R. & Schreiber, S.L. (1997). Small molecule-dependent genetic selection in stochastic nanodroplets as a means of detecting protein-ligand interactions on a large scale. Chem. Biol. 4, 961-968.
52. Huang, J. & Schreiber, S.L. (1997). A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. Proc. Natl Acad Sci. USA 94, 13396-13401.
53. Combs, A.P., Kapoor, T.M., Feng, S., Chen, J.K., Snow, LF. & Schreiber, S.L. (1996). Protein structure-based combinatorial chemistry: Discovery of non-peptide binding elements to src SH3 domain. J. Am. Chem. Soc. 118, 287-288.
54. Cook, J.A. & Mitchell, J.B. (1989). Viability measurements in mammalian cell systems. Anal. Biochem. 179, 1-7.
55. Silverman, L., Campbell, R. & Broach, J.R. (1998). New assay technologies for high-throughput screening. Curr. Opin. Chem. Biol. 2, 397-403.
56. DeRisi, J.L., Iyer, V.R. & Brown, P.O. (1997). Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680-686.
57. Clark, A.M. (1996). Natural products as a resource for new drugs. Pharm. Res. 13, 1133-1144.
58. Kwon, H.J., Owa, T., Hassig, C.A., Shimada, J. & Schreiber, S.L. (1998). Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl Acad. Sci. USA 95, 3356-3361.
59. Licitra, E.J. & Liu, J.O. (1996). A three-hybrid system for detecting small ligand-protein receptor interactions. Proc. Natl Acad. Sci. USA 93, 12817-12821.
60. King, R.W., Lustig, K.D., Stukenberg, P.T., McGarry, T.J. & Kirschner, M.W. (1997). Expression cloning in the test tube. Science 277, 973-974.
61. Stockwell, B.R. & Schreiber, S.L. (1998). Probing the role of homomeric and heteromeric receptor interactions in TGF-β signaling using small molecule dimerizers. Curr. Biol. 8, 761 -770.